Lesniak MS - Search Results

1

Sui generis: gene therapy and delivery systems for the treatment of glioblastoma.

Kane JR, Miska J, Young JS, Kanojia D, Kim JW, Lesniak MS. Kane JR, et al. Among authors: lesniak ms. Neuro Oncol. 2015 Mar;17 Suppl 2(Suppl 2):ii24-ii36. doi: 10.1093/neuonc/nou355. Neuro Oncol. 2015. PMID: 25746089 Free PMC article. Review.

2

Gene therapy for malignant glioma.

Lesniak MS. Lesniak MS. Expert Rev Neurother. 2006 Apr;6(4):479-88. doi: 10.1586/14737175.6.4.479. Expert Rev Neurother. 2006. PMID: 16623647 Review.

3

Oncolytic adenoviral therapy for glioblastoma multiforme.

Sonabend AM, Ulasov IV, Han Y, Lesniak MS. Sonabend AM, et al. Among authors: lesniak ms. Neurosurg Focus. 2006 Apr 15;20(4):E19. Neurosurg Focus. 2006. PMID: 16709024 Review.

4

Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.

Ulasov IV, Rivera AA, Sonabend AM, Rivera LB, Wang M, Zhu ZB, Lesniak MS. Ulasov IV, et al. Among authors: lesniak ms. Cancer Biol Ther. 2007 May;6(5):679-85. doi: 10.4161/cbt.6.5.3957. Epub 2007 Feb 3. Cancer Biol Ther. 2007. PMID: 17404502 Free article.

5

An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.

Ulasov IV, Rivera AA, Nettelbeck DM, Rivera LB, Mathis JM, Sonabend AM, Tyler M, Wang M, Douglas JT, Lesniak MS. Ulasov IV, et al. Among authors: lesniak ms. Int J Oncol. 2007 Nov;31(5):1177-85. Int J Oncol. 2007. PMID: 17912445

6

Vector therapies for malignant glioma: shifting the clinical paradigm.

Tyler MA, Sonabend AM, Ulasov IV, Lesniak MS. Tyler MA, et al. Among authors: lesniak ms. Expert Opin Drug Deliv. 2008 Apr;5(4):445-58. doi: 10.1517/17425247.5.4.445. Expert Opin Drug Deliv. 2008. PMID: 18426385 Review.

7

Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy.

Ulasov IV, Tyler MA, Rivera AA, Nettlebeck DM, Douglas JT, Lesniak MS. Ulasov IV, et al. Among authors: lesniak ms. J Med Virol. 2008 Sep;80(9):1595-603. doi: 10.1002/jmv.21264. J Med Virol. 2008. PMID: 18649343 Free PMC article.

8

Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.

Tyler MA, Ulasov IV, Sonabend AM, Nandi S, Han Y, Marler S, Roth J, Lesniak MS. Tyler MA, et al. Among authors: lesniak ms. Gene Ther. 2009 Feb;16(2):262-78. doi: 10.1038/gt.2008.165. Epub 2008 Dec 11. Gene Ther. 2009. PMID: 19078993 Free PMC article.

9

Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.

Ulasov IV, Tyler MA, Zhu ZB, Han Y, He TC, Lesniak MS. Ulasov IV, et al. Among authors: lesniak ms. Int J Oncol. 2009 Mar;34(3):729-42. doi: 10.3892/ijo_00000199. Int J Oncol. 2009. PMID: 19212678 Free PMC article.

10

Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.

Kranzler J, Tyler MA, Sonabend AM, Ulasov IV, Lesniak MS. Kranzler J, et al. Among authors: lesniak ms. Curr Gene Ther. 2009 Oct;9(5):389-95. doi: 10.2174/156652309789753347. Curr Gene Ther. 2009. PMID: 19860653 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters